A Study to Investigate GSK5733584 as Maintenance Treatment for Participants With MMRp Endometrial Cancer (BEHOLD-Endometrial02)

Clinical trial NCT07684599 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07684599
Sponsor: GlaxoSmithKline
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Neoplasms, Endometrial

Start date: 2026-09-03
Primary completion: 2029-07-23
Enrollment: 610

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.